BamSEC and AlphaSense Join Forces
Learn More

Savara Inc.

NASDAQ: SVRA    
Share price (12/24/24): $3.20    
Market cap (12/24/24): $549 million

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.6
from S-4 40 pages Business Transfer Agreement Relating to the Business of Serendex Pharmaceuticals a/S (Company Reg. No. (Cvr) 30532229) Pharmaorigin Aps (Company Reg. No. (Cvr) 29178291) Drugrecure Aps (Company Reg. No. (Cvr) 29154406) Jkm/Jkm/1037031 Contents
12/34/56
EX-2.3
from 425 15 pages Voting Agreement
12/34/56
EX-2.3
from 8-K 15 pages Voting Agreement
12/34/56
EX-2.2
from 8-K 14 pages Voting Agreement
12/34/56
EX-2.2
from 425 14 pages Voting Agreement
12/34/56
EX-2.1
from 8-K 80 pages Agreement and Plan of Merger and Reorganization by and Among Mast Therapeutics, Inc., Victoria Merger Corp., and Savara Inc., Dated as of January 6, 2017
12/34/56
EX-2.1
from 425 80 pages Agreement and Plan of Merger and Reorganization by and Among Mast Therapeutics, Inc., Victoria Merger Corp., and Savara Inc., Dated as of January 6, 2017
12/34/56
EX-2.1
from 10-Q 66 pages Agreement and Plan of Merger by and Among Mast Therapeutics, Inc. Ap Acquisition Sub, Inc. and Aires Pharmaceuticals, Inc. and Fortis Advisors LLC, in Its Capacity as Stockholders’ Representative
12/34/56
EX-2.1
from DEFA14A 103 pages Agreement and Plan of Merger by and Among Adventrx Pharmaceuticals, Inc. Srx Acquisition Corporation Synthrx, Inc. and Martin Emanuele, as Stockholders’ Agent Dated as of February 12, 2011
12/34/56
EX-2.1
from 8-K 103 pages Agreement and Plan of Merger by and Among Adventrx Pharmaceuticals, Inc. Srx Acquisition Corporation Synthrx, Inc. and Martin Emanuele, as Stockholders’ Agent Dated as of February 12, 2011
12/34/56
EX-2.1
from 8-K/A 102 pages Agreement and Plan of Merger by and Among Adventrx Pharmaceuticals, Inc., Speed Acquisition, Inc., Sd Pharmaceuticals, Inc., the Founders and the Stockholder Representative Dated as of April 7, 2006
12/34/56
EX-2.1
from 10SB12G ~50 pages Plan of reorganization, merger, acquisition or similar
12/34/56